Birgitte Bjørnhart

Efficacy and safety of immune checkpoint inhibitors in a Danish real life non-small cell lung cancer population: a retrospective cohort study

Birgitte Bjørnhart, Karin Holmskov Hansen, Trine Lembrecht Jørgensen et al. · Acta Oncologica · 2019 · 51 citations · Full text

Medicine, Immunology, Oncology +17

Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy

Mette Thune Mouritzen, Andreas Carus, Morten Ladekarl et al. · Cancers · 2021 · 41 citations · Full text

Medicine, Immunology, Oncology +17

Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study

Mette Thune Mouritzen, Karen F. Junker, Andreas Carus et al. · Acta Oncologica · 2022 · 19 citations · Full text

Medicine, Oncology, Pharmacology +15

Cartilage Oligomeric Matrix Protein in Patients with Juvenile Idiopathic Arthritis: Relation to Growth and Disease Activity

Birgitte Bjørnhart, Anders Juul, Susan Searles Nielsen et al. · The Journal of Rheumatology · 2009 · 15 citations · Full text

Medicine, Immunology, Pediatrics +17

Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy

Birgitte Bjørnhart, Charlotte Kristiansen, Jon Thor Asmussen et al. · Thrombosis Research · 2022 · 15 citations

Medicine, Immunology, Oncology +16